Current NIDA CTN studies led by NY Node Investigators

NY Node Administration
Contact: Ryan McDonald, Node Coordinator
Phone: 646-754-4795
Email: Ryan.Mcdonald@NYULangone.org

Low-threshold Buprenorphine Treatment at Syringe Services Programs: A Type I Hybrid Effectiveness-implementation Trial (CTN-0155)

More about CTN-0155 study
NYN Investigators: Aaron Fox, Aimee Campbell
Contact: ADFOX@montefiore.org

Better Together: Integrating MOUD in African American Community Settings (CTN-0144)

More about CTN-0144
NYN Investigator: Ayana Jordan
Contact: Ayana.Jordan@NYULangone.org

Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care; CTN-0139)

More about CTN-0139
NYN Investigator: Jennifer McNeely
Contact: Jennifer.Mcneely@NYULangone.org

Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment – A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial (CTN-0131)

More about CTN-0131
NYN Investigator: Ayana Jordan
Contact: Ayana.Jordan@NYULangone.org

Longitudinal Follow-up of Individuals with Opioid Use Disorder (CTN-0126)

More about CTN-0126
NYN Investigator: Edward Nunes
Contact: edward.nunes@nyspi.columbia.edu

Optimal Policies to Improve Methadone Maintenance Adherence Long-Term (OPTIMMAL; CTN-0112)

More about CTN-0112
NYN Investigators: A. Robin Williams, Noa Krawczyk
Contact: aw2879@columbia.edu

Subthreshold Opioid Use Disorder Prevention (STOP) Trial (CTN-0101)

More about CTN-0101
NYN Investigator: Jennifer McNeely
Contact: Jennifer.Mcneely@NYULangone.org

Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (CTN-0100)

More about CTN-0100
NYN Investigator(s): Edward Nunes, John Rotrosen
Contact: edward.nunes@nyspi.columbia.edu

Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (CTN-0097)

More about CTN-0097
NYN Investigator: Adam Bisaga
Contact: adam.bisaga@nyspi.columbia.edu

Culturally Centering Delivery of Medications for OUD with American Indian/Alaska Native Communities (CTN-0096)

More about CTN-0096
NYN Investigator: Aimee Campbell
Contact: anc2002@cumc.columbia.edu

Ancillary Study of the Adoption and Sustainability of ED-Initiated Buprenorphine (CTN-0079-A1)

More about CTN-0079-A1
NYN Investigator: Ryan McCormack
Contact: Ryan.McCormack@NYULangone.org

Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT; CTN-0079)

More about CTN-0079
NYN Investigator: Ryan McCormack
Contact: Ryan.McCormack@NYULangone.org